Frontiers in Cell and Developmental Biology (Jan 2022)

Pathogenic Variations of Homologous Recombination Gene HSF2BP Identified in Sporadic Patients With Premature Ovarian Insufficiency

  • Shan Li,
  • Shan Li,
  • Shan Li,
  • Shan Li,
  • Shan Li,
  • Weiwei Xu,
  • Weiwei Xu,
  • Weiwei Xu,
  • Weiwei Xu,
  • Weiwei Xu,
  • Bingying Xu,
  • Bingying Xu,
  • Bingying Xu,
  • Bingying Xu,
  • Bingying Xu,
  • Shuchang Gao,
  • Shuchang Gao,
  • Shuchang Gao,
  • Shuchang Gao,
  • Shuchang Gao,
  • Qian Zhang,
  • Qian Zhang,
  • Qian Zhang,
  • Qian Zhang,
  • Qian Zhang,
  • Yingying Qin,
  • Yingying Qin,
  • Yingying Qin,
  • Yingying Qin,
  • Yingying Qin,
  • Ting Guo,
  • Ting Guo,
  • Ting Guo,
  • Ting Guo,
  • Ting Guo

DOI
https://doi.org/10.3389/fcell.2021.768123
Journal volume & issue
Vol. 9

Abstract

Read online

Premature ovarian insufficiency (POI) is defined as depletion of ovarian function before 40 years of age, which affects 3.7% of women in reproductive age. The etiology of POI is heterogeneous. Recently, with the widespread use of whole-exome sequencing (WES), the DNA repair genes, especially for those involved in meiosis progress, were enriched in the causative gene spectrum of POI. In this study, through the largest in-house WES database of 1,030 patients with sporadic POI, we identified two novel homozygous variations in HSF2BP (c.382T>C, p.C128R; c.557T>C, p.L186P). An in vitro functional study revealed that both variations impaired the nuclear location of HSF2BP and affected its DNA repair capacity. Our studies highlighted the essential role of meiotic homologous recombination genes in the pathogenesis of sporadic POI.

Keywords